Switch-ON the future
NanoHybrid is a technology platform based on proprietary, ready-to-use nanoreagents enabling instantaneous detection protein biomarkers (such as antibodies) in complex matrices such as blood serum. Ulisse BioMed is developing the technology both in a lab format and in a point-of-care version. What makes our products unique is the flexibility of our technology, which enables us to bring the diagnostic answer exactly where and when is needed.